Clovis Oncology, Inc. (Nasdaq:CLVS) reported that it has reached the target enrollment in its pivotal LEAP (Low hENT1 and Adenocarcinoma of the Pancreas) study of CO-101 in metastatic pancreatic cancer.
CO-101 is the Company?s lipid-conjugated form of the anti-cancer drug gemcitabine.
Crown Equity Holdings Inc. offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. Crown Equity Holdings advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.
Crown Equity Holdings Inc. (CRWE) recently announced that its subsidiary Crown Tele Services Inc. has entered into a letter of intent with BBN Solutions. In addition, Crown Equity Holdings Inc. previously announced that its subsidiary Crown Tele Services Inc. has entered into a letter of intent with MVOX AG.
BBN Solutions, located in India, and Crown Tele Services Inc., a subsidiary of CRWE shall form a 50/50 Joint Venture corporation for the purpose of granting to Crown Tele Services Inc., exclusive rights in the United States to BBN?s telecommunications marketing process and services.
BBN Solutions doing business as BBN Telecom provides both wholesale and retail global communication, as well as calling cards. For more information visit https://www.bbntel.net
MVOX AG, located in Germany, will work with Crown Tele Services Inc. as a technological partner in offering wireless broadband solutions (wireless carrier class infrastructure in high speed data and WiMAX).
Crown Tele Services, a subsidiary of CRWE is a leading provider of affordable, world class VoIP communications solutions, with a network utilizing fast fiber optic channels throughout the world, exploiting the power of IP with unified communication tools that anyone can use.
For more information about Crown Equity Holdings Inc. please visit http://www.crownequityholdings.com
For more information about Crown Tele Services Inc. please visit http://crownteleservices.com
AstraZeneca (NYSE:AZN) reported that on March 23, 2012 the US District Court for the District of Columbia issued an opinion and order in AstraZeneca?s lawsuit against the US Food and Drug Administration (FDA) regarding final marketing approval of generic quetiapine. The Court denied the Company?s request for a preliminary injunction and dismissed the lawsuit without prejudice.
Notwithstanding the Court?s decision, the Company continues to believe strongly in the merits of its position and is evaluating its options.
BioClinica, Inc. (NASDAQ:BIOC), a global provider of clinical trial management solutions, is quickly becoming the eClinical provider of choice for European pharmaceutical, medical device, biotechnology and contract research organizations (CROs).
BioClinica?s combination of nimble programing, scalability, ease of use, and high value are winning the attention of European companies tired of outdated, slow-moving, cumbersome eClinical systems.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. BestOtc.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://bestotc.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold BestOTC.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.